CTKB - Cytek BioSciences Inc
IEX Last Trade
5.735
0.045 0.785%
Share volume: 489,773
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$5.69
0.05
0.79%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-10 | 2022-11-09 | 2023-03-01 | 2023-05-09 | 2023-08-08 | 2023-11-14 | 2024-03-13 | 2024-05-08 | |
| Assets | |||||||||
| Total Assets | 492.817 M | 499.295 M | 519.476 M | 524.575 M | 525.054 M | 519.430 M | 494.457 M | 492.067 M | |
| Current Assets | 443.270 M | 443.859 M | 454.020 M | 425.622 M | 424.821 M | 422.315 M | 392.060 M | 388.647 M | |
| Inventories | 45.345 M | 49.369 M | 48.154 M | 69.502 M | 65.731 M | 66.875 M | 60.877 M | 54.742 M | |
| Other Current Assets | 10.848 M | 12.959 M | 10.943 M | 9.096 M | 8.153 M | 9.786 M | 12.322 M | 13.094 M | |
| Short Term Investments | 10.848 M | 12.959 M | 10.943 M | 9.096 M | 8.153 M | 9.786 M | 12.322 M | 13.094 M | |
| Total Receivables | 37.183 M | 40.008 M | 50.875 M | 45.111 M | 52.099 M | 57.633 M | 56.120 M | 50.372 M | |
| Current Cash | 349.894 M | 341.523 M | 341.149 M | 298.995 M | 298.838 M | 288.021 M | 262.410 M | 270.086 M | |
| Total Non-current Assets | 49.547 M | 55.436 M | 65.456 M | 98.953 M | 100.233 M | 97.115 M | 102.397 M | 103.420 M | |
| Property Plant Equipment | 7.340 M | 7.844 M | 13.682 M | 15.549 M | 15.588 M | 17.415 M | 18.405 M | 18.247 M | |
| Other Assets | 2.880 M | 4.559 M | 2.957 M | 3.006 M | 3.009 M | 3.168 M | 3.385 M | 4.081 M | |
| Intangible Assets | 3.859 M | 4.485 M | 4.331 M | 24.664 M | 23.683 M | 24.292 M | 23.084 M | 22.252 M | |
| Goodwill | 10.144 M | 10.144 M | 10.144 M | 19.143 M | 19.143 M | 16.457 M | 16.183 M | 16.183 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 492.817 M | 499.295 M | 519.476 M | 524.575 M | 525.054 M | 519.430 M | 494.457 M | 492.067 M | |
| Total liabilities | 81.790 M | 82.848 M | 94.181 M | 101.115 M | 100.875 M | 103.906 M | 101.393 M | 99.453 M | |
| Total current liabilities | 42.350 M | 41.494 M | 49.040 M | 56.517 M | 53.591 M | 58.693 M | 56.226 M | 55.566 M | |
| Accounts Payable | 6.749 M | 5.640 M | 4.805 M | 5.280 M | 3.082 M | 4.711 M | 3.032 M | 3.725 M | |
| Other liabilities | 27.022 M | 26.966 M | 30.307 M | 30.924 M | 34.569 M | 33.338 M | 34.040 M | 33.713 M | |
| Current long term debt | 0.000 | 0.000 | 580.000 K | 582.000 K | 551.000 K | 548.000 K | 565.000 K | 1.939 M | |
| Long term debt | 0.000 | 0.000 | 2.271 M | 2.133 M | 1.882 M | 1.736 M | 1.648 M | 1.477 M | |
| Other liabilities | 27.022 M | 26.966 M | 30.307 M | 30.924 M | 34.569 M | 33.338 M | 34.040 M | 33.713 M | |
| Minority interest | 102.000 K | 62.000 K | 251.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 411.027 M | 416.447 M | 425.295 M | 423.460 M | 424.179 M | 415.524 M | 393.064 M | 392.614 M | |
| Common stock | 134.403 M | 134.712 M | 135.026 M | 135.489 M | 135.919 M | 136.173 M | 133.551 M | 130.921 M | |
| Retained earnings | -22.225 M | -20.559 M | -17.030 M | -23.837 M | -28.225 M | -34.681 M | -29.178 M | -35.347 M |